SABA Ilac Sanayi ve Ticaret

Saba İlaç Sanayi ve Ticaret is a Turkish pharmaceutical company founded in 1967, specializing in the development, manufacturing, and marketing of a wide range of pharmaceutical products. The company focuses on several therapeutic areas, including cardiovascular health, central nervous system disorders, respiratory diseases, and anti-infectives. In 2014, Saba İlaç was acquired by Santa Farma, one of Turkey's leading pharmaceutical companies, which helped expand its production capabilities and market reach. Saba İlaç operates with a commitment to high-quality standards, providing both branded and generic medications to the Turkish and international markets. With a long history in the Turkish healthcare sector, the company maintains a robust portfolio of essential medicines and continues to operate as a key subsidiary within the Santa Farma group.